Plasma contact system, kallikrein-kinin system and antiphospholipid-protein antibodies in thrombosis and pregnancy

被引:10
作者
Sugi, T [1 ]
Makino, T [1 ]
机构
[1] Tokai Univ, Sch Med, Dept Obstet & Gynecol, Isehara, Kanagawa 2591193, Japan
关键词
antiphospholipid antibody; pregnancy loss; thrombosis; kininogen; factor XII; prekallikrein;
D O I
10.1016/S0165-0378(00)00061-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Coagulation factor XII, prekallikrein and high molecular weight kininogen are known as plasma contact proteins in the intrinsic pathway of blood coagulation. Deficiencies of these proteins are not associated with clinical bleeding despite marked prolongation of in vitro surface-activated coagulation time. Paradoxically, studies suggest that these proteins have anticoagulant and profibrinolytic activities. In fact, association between deficiencies of these proteins as well as recurrent thrombosis has been reported. Also deficiencies of these proteins and antiphospholipid antibodies are frequent haemostasis-related abnormalities found in unexplained recurrent aborters. Recently, evidence has accumulated for the presence of the kallikrein-kinin system or plasma contact system in the fetoplacental unit. This suggests that the plasma contact system may also have an important role in pregnancy. Several studies have reported the presence of autoantibodies to the contact proteins in patients with SLE, thrombosis and recurrent pregnancy loss. These autoantibodies are often in association with antiphospholipid antibodies and lupus anticoagulants. Contact proteins may be added to the list of proteins to which autoantibodies are produced in patients assigned to antiphospholipid antibody syndrome. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:169 / 184
页数:16
相关论文
共 95 条
[1]  
ABERG H, 1972, ACTA MED SCAND, V192, P419
[2]   QUANTIFICATION OF RAT T-KININOGEN USING IMMUNOLOGICAL METHODS - APPLICATION TO INFLAMMATORY PROCESSES [J].
ADAM, A ;
DAMAS, J ;
CALAY, G ;
RENARD, C ;
REMACLEVOLON, G ;
BOURDON, V .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (10) :1569-1575
[3]   ORGANIZATION OF THE GENE FOR HUMAN FACTOR-XI [J].
ASAKAI, R ;
DAVIE, EW ;
CHUNG, DW .
BIOCHEMISTRY, 1987, 26 (23) :7221-7228
[4]  
BERARD M, 1995, NOUV REV FR HEMATOL, V37, pS69
[5]   CHANGES IN MEMBRANE PHOSPHOLIPID DISTRIBUTION DURING PLATELET ACTIVATION [J].
BEVERS, EM ;
COMFURIUS, P ;
ZWAAL, RFA .
BIOCHIMICA ET BIOPHYSICA ACTA, 1983, 736 (01) :57-66
[6]   BLOOD PROTEIN DEFECTS ASSOCIATED WITH THROMBOSIS - LABORATORY ASSESSMENT [J].
BICK, RL ;
ANCYPA, D .
CLINICS IN LABORATORY MEDICINE, 1995, 15 (01) :125-163
[7]  
Boffa MC, 1996, J RHEUMATOL, V23, P1375
[8]  
BOUMA GN, 1978, J LAB CLIN MED, V91, P148
[9]   Criteria for antiphospholipid syndrome: Early pregnancy loss, fetal loss, or recurrent pregnancy loss? [J].
Branch, DW ;
Silver, RM .
LUPUS, 1996, 5 (05) :409-413
[10]   OBSTETRIC COMPLICATIONS ASSOCIATED WITH THE LUPUS ANTICOAGULANT [J].
BRANCH, DW ;
SCOTT, JR ;
KOCHENOUR, NK ;
HERSHGOLD, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (21) :1322-1326